INS and hypertriglyceridemia: The AI-induced improvement of hypertriglyceridemia appears to be exerted at two different levels: first, by decreasing lipid availability through stimulation of adiponectin-AMPK mediated signaling cascades; and second, by downregulating molecules involved in TG-rich lipoprotein assembly through improved hepatic insulin resistance.